Gunilla Skoog

Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial

Torsten Sandberg, Gunilla Skoog, Anna Bornefalk‐Hermansson et al. · The Lancet · 2012 · 185 citations

Urology, Antibiotics, Antimicrobial Stewardship +4

Lessons learnt during 20 years of the Swedish strategic programme against antibiotic resistance

Sigvard Mölstad, Sonja Löfmark, Karin Carlin et al. · Bulletin of the World Health Organization · 2017 · 177 citations · Full text

Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009

Peter Zarb, Brice Amadéo, Arno Müller et al. · Journal of Antimicrobial Chemotherapy · 2010 · 154 citations · Full text

Penicillin V four times daily for five days versus three times daily for 10 days in patients with pharyngotonsillitis caused by group A streptococci: randomised controlled, open label, non-inferiority study

Gunilla Skoog, Mia Tyrstrup, Charlotta Edlund et al. · BMJ · 2019 · 57 citations · Full text

The clinical and microbiological efficacy of temocillin versus cefotaxime in adults with febrile urinary tract infection, and its effects on the intestinal microbiota: a randomised multicentre clinical trial in Sweden

Charlotta Edlund, Anders Ternhag, Gunilla Skoog et al. · The Lancet Infectious Diseases · 2021 · 43 citations

Probiotic, Antimicrobial Susceptibility, Health Sciences +14